- Home
- Equipment
- usa connecticut
- in vitro
Refine by
In Vitro Equipment Supplied In Usa Connecticut
8 equipment items found
by:Precipio, Inc based inNew Haven, CONNECTICUT (USA)
Precipio’s HemeScreen Anemia Panel offerings are in vitro medical diagnostic assays that screen for clinically actionable somatic mutations in targets of interest related to Anemia. This Research Use Only (RUO) assay is specifically designed to screen for mutations using High Resolution Melt Analysis in ASXL1, DNMT3A, TERT, RUNX1, WT1. ...
by:Precipio, Inc based inNew Haven, CONNECTICUT (USA)
Precipio’s HemeScreen acute myeloid leukemia AML Panel offerings are in vitro diagnostic assays that screen for clinically actionable somatic mutations in targets of interest related to AML. This Research Use Only (RUO) assay is specifically designed to screen for mutations using High Resolution Melt Analysis in genes that are of clinical relevance: IDH1, IDH2, FLT3, KIT, ...
by:Precipio, Inc based inNew Haven, CONNECTICUT (USA)
IV-Cell universal culture media is a Research-use only (RUO), ready-to-use, fully supplemented medium developed specifically to support bone marrow and peripheral blood cell culture for in vitro cytogenetic analysis of hematological disease. IV-Cell is a proprietary culture media that does not require the addition of any mitogens. Additionally, it enables simultaneous culturing ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
BiomX develops phage cocktails (or combinations) that target and kill specific pathogenic bacteria. Our phage cocktails, which are optimized through algorithms and experimental validation (in-vitro and in-vivo), contain multiple natural and/or engineered phage. The phage are selected to have complementary functions such as wide target bacterial host range and the ability to avoid ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
This program leverages know-how and capabilities acquired under our previous programs with regard to topical formulation and clinical testing. In preclinical in vitro studies, BX005 was shown to be active against over 90% of strains of S. aureus isolated from the skin of subjects from U.S. and Europe, including antibiotic resistant strains. ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro has spent 20 years specializing in neuroscience imaging solutions for preclinical, early phase and late phase clinical studies. Our capabilities span from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials. We have expertise in coordinating worldwide multi-center imaging studies, and providing ...
by:Valo Health, Inc. based inBoston, MASSACHUSETTS (USA)
Our Biowire II platform applies biomimetic stimulation to produce engineered cardiac tissue with unprecedented adult-like human physiology. Our tissues overcome the limitations of current technology by more accurately & more quickly predicting the efficacy & safety of new medicines in early ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
We are developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa (P. aeruginosa) respiratory infections, a main contributor to morbidity and mortality in this disease. Phase 1b/2a clinical study in CF patients is composed of two parts. Results from Part 1 aimed to evaluate the safety, pharmacokinetics, and microbiologic/clinical activity are expected in Q3 of 2022. ...